GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinhe Biotechnology Co Ltd (SZSE:002688) » Definitions » Total Long-Term Liabilities

Jinhe Biotechnology Co (SZSE:002688) Total Long-Term Liabilities : ¥1,186 Mil (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Jinhe Biotechnology Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Jinhe Biotechnology Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥1,186 Mil.

Jinhe Biotechnology Co Total Long-Term Liabilities Historical Data

The historical data trend for Jinhe Biotechnology Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhe Biotechnology Co Total Long-Term Liabilities Chart

Jinhe Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 254.82 204.35 418.58 679.80 1,289.52

Jinhe Biotechnology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 961.26 1,147.51 1,351.81 1,289.52 1,186.08

Jinhe Biotechnology Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Jinhe Biotechnology Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Jinhe Biotechnology Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinhe Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinhe Biotechnology Co Ltd (SZSE:002688) » Definitions » Total Long-Term Liabilities
Comparable Companies
SHSE:688566 SZSE:301211 SZSE:300194 SHSE:603439 SZSE:002581 SZSE:002900 SZSE:002793 SHSE:603207 SHSE:688176 SHSE:603676 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 71, Xinping Road, Inner Mongolia Autonomous Region, Tuoketuo County, Hohhot, CHN, 010200
Website
https://www.jinhe.com.cn
Jinhe Biotechnology Co Ltd is engaged in manufacturing veterinary feed additives, veterinary vaccines, veterinary chemicals, corn starch processing and industrial wastewater treatments business.
Executives
Wang Zhi Jun Directors, executives
Liu Ying Chun Executives
Deng Yi Xin Secretary Dong
Li Fu Zhong Director
Liu Yun Tian Directors, executives
Xie Chang Xian Directors, executives
Wang Dong Xiao Director
Yao Jian Xiong Supervisors
Zheng Liu Ji Supervisors
Niu You Shan Executives
Wu Ming Xia Director
Li Wei Qi Directors, executives
Wu Rui Gang Executives

Jinhe Biotechnology Co Headlines

No Headlines